Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Inventory (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Change in Inventory data on record, last reported at $2.9 million in Q4 2025.

  • For Q4 2025, Change in Inventory rose 215.74% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $5.4 million, up 138.44%, while the annual FY2025 figure was $5.4 million, 138.44% up from the prior year.
  • Change in Inventory reached $2.9 million in Q4 2025 per COLL's latest filing, up from -$96000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $8.1 million in Q3 2023 and bottomed at -$18.2 million in Q4 2022.
  • Average Change in Inventory over 5 years is -$3.4 million, with a median of -$1.4 million recorded in 2023.
  • Peak YoY movement for Change in Inventory: tumbled 50516.67% in 2022, then surged 257.01% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $36000.0 in 2021, then crashed by 50516.67% to -$18.2 million in 2022, then soared by 90.12% to -$1.8 million in 2023, then plummeted by 37.87% to -$2.5 million in 2024, then surged by 215.74% to $2.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $2.9 million in Q4 2025, -$96000.0 in Q3 2025, and $930000.0 in Q2 2025.